---
figid: PMC6770250__cells-08-00960-g002
figtitle: TGFB signaling in cholangiocarcinoma (CCA) progression
organisms:
- Fasciola hepatica
- Clonorchis sinensis
- Opisthorchis viverrini
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Danio rerio
- Veratrum californicum
- NA
pmcid: PMC6770250
filename: cells-08-00960-g002.jpg
figlink: /pmc/articles/PMC6770250/figure/cells-08-00960-f002/
number: F2
caption: TGFβ signaling in cholangiocarcinoma (CCA) progression. TGFβ activates SMAD-dependent
  (canonical) and SMAD-independent (non-canonical) pathways in order to evoke transcriptional
  programs that, ultimately, regulate physiological responses in CCA. Consistent with
  its dual role in cancer, TGFβ can either prevent CCA progression, by inducing apoptosis,
  or enhance CCA progression, by promoting EMT, migration, invasion, and suppression
  of the immune system. Many coding and noncoding TGFβ-target genes can mediate the
  effects of the pathway during CCA progression and a number of them could potentially
  serve as drugable targets and biomarkers of CCA. Current therapeutic approaches
  aim at targeting components of the core pathway, such as the TGFβ ligands and the
  type I TGFβ receptor (TβRI).
papertitle: Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma.
reftext: Panagiotis Papoutsoglou, et al. Cells. 2019 Sep;8(9):960.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9490131
figid_alias: PMC6770250__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Danio rerio
redirect_from: /figures/PMC6770250__F2
ndex: c3014e09-dede-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6770250__cells-08-00960-g002.html
  '@type': Dataset
  description: TGFβ signaling in cholangiocarcinoma (CCA) progression. TGFβ activates
    SMAD-dependent (canonical) and SMAD-independent (non-canonical) pathways in order
    to evoke transcriptional programs that, ultimately, regulate physiological responses
    in CCA. Consistent with its dual role in cancer, TGFβ can either prevent CCA progression,
    by inducing apoptosis, or enhance CCA progression, by promoting EMT, migration,
    invasion, and suppression of the immune system. Many coding and noncoding TGFβ-target
    genes can mediate the effects of the pathway during CCA progression and a number
    of them could potentially serve as drugable targets and biomarkers of CCA. Current
    therapeutic approaches aim at targeting components of the core pathway, such as
    the TGFβ ligands and the type I TGFβ receptor (TβRI).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tgfb1
  - Ltbp1
  - Tgfbr1
  - Tgfbr2
  - Smad2
  - Smad3
  - Pik3r1
  - Map2k4
  - Akt1
  - ras
  - Hras
  - Kras
  - Rem1
  - Map2k3
  - Map2k6
  - Mapk8
  - Smad4
  - Mdk
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Ephb2
  - Mapk1
  - Itk
  - Slc22a3
  - Igkv4-59
  - TGFB1
  - TGFB2
  - TGFB3
  - FBN2
  - TGFBR1
  - TGFBR2
  - SMAD2
  - SMAD3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - MAP2K4
  - AKT1
  - AKT2
  - AKT3
  - KRAS
  - HRAS
  - NRAS
  - MAP2K3
  - MAP2K6
  - MAPK8
  - MAPK9
  - MAPK10
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - EPHB2
  - MAPK3
  - ITK
  - SLC22A3
  - Pik3cg
  - Ephb1
  - smad2
  - smad3a
  - map2k4a
  - rab1ab
  - map2k6
  - mapk8b
  - smad4a
  - smad4b
  - mapk14a
  - tumor
---
